NeuroPace (NPCE) Change in Accured Expenses (2020 - 2026)
NeuroPace (NPCE) posted quarterly Change in Accured Expenses of -$4.0 million for Q1 2026, down 71.24% year-over-year from -$13.9 million in Q1 2025, and down 490.9% quarter-over-quarter from $1.0 million in Q4 2025.
NeuroPace (NPCE) Change in Accured Expenses (2020 - 2026) Analysis & Trends
NeuroPace's Change in Accured Expenses history runs 7 years deep, the most recent figure standing at -$4.0 million for Q1 2026.
- In Q1 2026, Change in Accured Expenses fell 71.24% year-over-year to -$4.0 million; the TTM figure through Mar 2026 stood at $1.9 million (up 1045.45% YoY), while the FY2025 annual figure was $3.6 million, up 355.17% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$4.0 million, down from $1.0 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $2.6 million in Q3 2025, with the low at -$4.0 million in Q1 2026.
- The 5-year median for Change in Accured Expenses is $454000.0 (2024), against an average of $112823.5.
- The sharpest annual moves came in 2023 and 2024: Change in Accured Expenses soared 39975.0% in 2023, then tumbled 366.43% in 2024.
- NeuroPace's Change in Accured Expenses stood at -$136000.0 in 2022, then surged by 941.91% to $1.1 million in 2023, then plunged by 124.8% to -$284000.0 in 2024, then jumped by 459.86% to $1.0 million in 2025, then tumbled by 490.9% to -$4.0 million in 2026.
- Business Quant data shows NPCE's Change in Accured Expenses at -$4.0 million in Q1 2026, $1.0 million in Q4 2025, and $2.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 4.80 Mn |
| 10 | NeuroPace | 479.51 Mn | 427.81 Mn | 18.91 Mn | 1.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.51 Mn |
| Jun 30, 2026 | 1.51 Mn |
| Mar 31, 2026 | -4.00 Mn |
| Mar 31, 2026 | -4.00 Mn |
| Dec 31, 2025 | 1.02 Mn |
| Dec 31, 2025 | 1.02 Mn |
| Sep 30, 2025 | 2.65 Mn |
| Sep 30, 2025 | 2.65 Mn |
| Jun 30, 2025 | 2.21 Mn |
| Jun 30, 2025 | 2.21 Mn |
| Mar 31, 2025 | -2.33 Mn |
| Mar 31, 2025 | -2.33 Mn |
| Dec 31, 2024 | -284,000.00 |
| Dec 31, 2024 | -284,000.00 |
| Sep 30, 2024 | 2.33 Mn |
| Sep 30, 2024 | 2.33 Mn |
| Jun 30, 2024 | 454,000.00 |
| Jun 30, 2024 | 454,000.00 |
| Mar 31, 2024 | -3.89 Mn |
| Mar 31, 2024 | -3.89 Mn |